369 related articles for article (PubMed ID: 30094585)
1. Investigation of intraoperative dosing patterns of neuromuscular blocking agents.
Palsen S; Wu A; Beutler SS; Gimlich R; Yang HK; Urman RD
J Clin Monit Comput; 2019 Jun; 33(3):455-462. PubMed ID: 30094585
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
Bash LD; Black W; Turzhitsky V; Urman RD
Anesth Analg; 2021 Dec; 133(6):1437-1450. PubMed ID: 34784330
[TBL] [Abstract][Full Text] [Related]
3. Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial.
Horrow JC; Li W; Blobner M; Lombard J; Speek M; DeAngelis M; Herring WJ
BMC Anesthesiol; 2021 Feb; 21(1):62. PubMed ID: 33639839
[TBL] [Abstract][Full Text] [Related]
4. Observational study on patterns of neuromuscular blockade reversal.
Dubovoy T; Housey M; Devine S; Kheterpal S
BMC Anesthesiol; 2016 Oct; 16(1):103. PubMed ID: 27770778
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
Bash LD; Turzhitsky V; Black W; Urman RD
Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
[TBL] [Abstract][Full Text] [Related]
6. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
[TBL] [Abstract][Full Text] [Related]
7. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
[TBL] [Abstract][Full Text] [Related]
8. The Nonirritating Concentrations of Neuromuscular Blocking Agents and Related Compounds.
Gonzalez-Estrada A; Carrillo-Martin I; Morgenstern-Kaplan D; Garzon-Siatoya WT; Renew JR; Hernandez-Torres V; Volcheck GW
J Allergy Clin Immunol Pract; 2023 Feb; 11(2):466-473.e5. PubMed ID: 36108924
[TBL] [Abstract][Full Text] [Related]
9. Optimal anesthetic regimen for ambulatory laser microlaryngeal surgery.
Huh H; Park SJ; Lim HH; Jung KY; Baek SK; Yoon SZ; Lee HW; Lim HJ; Cho JE
Laryngoscope; 2017 May; 127(5):1135-1139. PubMed ID: 27796041
[TBL] [Abstract][Full Text] [Related]
10. Rocuronium priming of atracurium-induced neuromuscular blockade: the use of short priming intervals.
Abdulatif M; al-Ghamdi A; el-Sanabary M
J Clin Anesth; 1996 Aug; 8(5):376-81. PubMed ID: 8832448
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
Carron M; Zarantonello F; Tellaroli P; Ori C
J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
[TBL] [Abstract][Full Text] [Related]
12. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
[TBL] [Abstract][Full Text] [Related]
13. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
[TBL] [Abstract][Full Text] [Related]
14. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction.
de Boer HD; Carlos RV; Brull SJ
BMC Anesthesiol; 2018 Nov; 18(1):159. PubMed ID: 30400850
[TBL] [Abstract][Full Text] [Related]
15. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
16. The incidence of residual neuromuscular blockade associated with single dose of intermediate-acting neuromuscular blocking drugs.
Kaan N; Kocaturk O; Kurt I; Cicek H
Middle East J Anaesthesiol; 2012 Feb; 21(4):535-41. PubMed ID: 23327026
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of Sugammadex Dosed by Actual and Ideal Body Weight in Patients With Morbid Obesity Undergoing Surgery.
Mostoller K; Wrishko R; Maganti L; Herring WJ; van Zutphen-van Geffen M
Clin Transl Sci; 2021 Mar; 14(2):737-744. PubMed ID: 33278332
[TBL] [Abstract][Full Text] [Related]
18. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
Fortier LP; McKeen D; Turner K; de Médicis É; Warriner B; Jones PM; Chaput A; Pouliot JF; Galarneau A
Anesth Analg; 2015 Aug; 121(2):366-72. PubMed ID: 25902322
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial evaluating the safety profile of sugammadex in high surgical risk ASA physical class 3 or 4 participants.
Herring WJ; Mukai Y; Wang A; Lutkiewicz J; Lombard JF; Lin L; Watkins M; Broussard DM; Blobner M
BMC Anesthesiol; 2021 Oct; 21(1):259. PubMed ID: 34711192
[TBL] [Abstract][Full Text] [Related]
20. Role of sugammadex in accelerating postoperative discharge: A meta-analysis.
Carron M; Zarantonello F; Lazzarotto N; Tellaroli P; Ori C
J Clin Anesth; 2017 Jun; 39():38-44. PubMed ID: 28494905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
